IL-1β Scavenging by the Type II IL-1 Decoy Receptor in Human Neutrophils
- 15 June 2003
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 170 (12) , 5999-6005
- https://doi.org/10.4049/jimmunol.170.12.5999
Abstract
IL-1 elicits its cellular effects by binding a heterodimeric receptor consisting of IL-1RI and the accessory protein, IL-1RAcPr. In addition, it binds to IL-1RII, which lacking signaling function has been ascribed a decoy role. The fate of the ligand following interaction with the decoy receptor was examined in human polymorphonuclear cells (PMN), which express predominantly (>90%) IL-1RII. Incubation of PMN with IL-1β results in a rapid decrease in cell surface-associated ligand accompanied by a concomitant increase in internalized IL-1 with 50–60% of IL-1β located intracellularly within 1 h at 37°C. The use of blocking Abs revealed that IL-1 internalization is mediated exclusively by the decoy receptor. The results of inhibitor analysis demonstrate that internalization requires ATP synthesis and involves clathrin-mediated endocytosis. Following removal of the ligand, the receptor was rapidly re-expressed on the cell surface. Cyclohexamide, a protein synthesis inhibitor, had no effect upon the process, suggesting that the re-expressed receptor was recycled. In addition, human keratinocytes stably transfected with IL-1RII (HaCAT 811) also internalized the IL-1RII with 43% cell surface receptor internalized after 90 min. Immunofluorescence microscopy revealed colocalization of the internalized receptor with wheat germ agglutinin-labeled internalized glycoproteins and early endosome Ag-1, a protein associated with the early endosome compartments, indicative of cellular uptake of IL-1RII by endocytosis. In contrast, little or no internalization was observed in other cells of immune origin. These results suggest that the decoy receptor IL-1RII can act as a scavenger of IL-1, representing a novel autoregulatory mechanism of the IL-1 system.Keywords
This publication has 39 references indexed in Scilit:
- Long‐term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin‐1 receptor antagonist) in patients with rheumatoid arthritis: Extension phase of a randomized, double‐blind, placebo‐controlled trialArthritis & Rheumatism, 2002
- Interleukin 1 in the brain: biology, pathology and therapeutic targetTrends in Neurosciences, 2000
- Soluble Cytokine Receptors: Their Roles in Immunoregulation, Disease, and TherapyPublished by Elsevier ,1996
- Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells.The Journal of Experimental Medicine, 1995
- Towards an understanding of the signal transduction pathways for interleukin 1Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1995
- The type II ‘decoy’ receptor: A novel regulatory pathway for interleukin 1Immunology Today, 1994
- The type II "receptor" as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor.The Journal of Experimental Medicine, 1994
- Signal-Dependent Membrane Protein Trafficking in the Endocytic PathwayAnnual Review of Cell Biology, 1993
- Interleukin-1 Type II Receptor: A Decoy Target for IL-1 That Is Regulated by IL-4Science, 1993
- Intracellular pathways and mechanisms of sorting in receptor-mediated endocytosisTrends in Pharmacological Sciences, 1989